SCHEMBL12189769

SCHEMBL12189769

Nc1nc(Cl)nc(Nc2ccc(/N=N/c3ccc(/N=N/c4cc(S(=O)(=O)O)ccc4S(=O)(=O)O)c4cc(S(=O)(=O)O)ccc34)c3cccc(S(=O)(=O)O)c23)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.51
▸ THRB P10828 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ FUT8 Q9BYC5 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.40
▸ CHAT P28329 4/20 0.39
▸ ENPP3 O14638 1/20 0.39
▸ ENPP1 P22413 1/20 0.39
▸ USP2 O75604 1/20 0.38
▸ APEX1 P27695 1/20 0.38
▸ SENP3 Q9H4L4 4/20 0.37
▸ SENP2 Q9HC62 4/20 0.37
▸ SENP1 Q9P0U3 4/20 0.37
▸ CYP1A2 P05177 3/20 0.37
▸ SUMO2 P61956 2/20 0.37
▸ SUMO1 P63165 2/20 0.37
▸ SENP7 Q9BQF6 2/20 0.37
▸ ATIC P31939 2/20 0.37
▸ HPGDS O60760 1/20 0.36
▸ HIF1A Q16665 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12172932 0.97 MEN1 (0.54) MEN1THRBKMT2AFUT8TDP1
SCHEMBL13539076 0.96 MEN1 (0.52) MEN1THRBKMT2AFUT8TDP1
SCHEMBL27876305 0.86 P2RY12 (0.40) MEN1THRBKMT2AFUT8TDP1
SCHEMBL13881030 0.85 MEN1 (0.53) MEN1THRBKMT2AFUT8TDP1
SCHEMBL13454515 0.84 MEN1 (0.45) MEN1THRBKMT2AFUT8TDP1
SCHEMBL20314641 0.84 MEN1 (0.47) MEN1THRBKMT2AFUT8CHAT
SCHEMBL13468871 0.83 SENP2 (0.47) MEN1THRBKMT2AFUT8TDP1
SCHEMBL13454504 0.83 SENP2 (0.47) MEN1THRBKMT2AFUT8TDP1
SCHEMBL13454500 0.83 SENP2 (0.50) MEN1THRBKMT2AFUT8TDP1
SCHEMBL13474893 0.82 SENP3 (0.38) MEN1THRBKMT2AFUT8TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9403987-B2 Charged particles BASF SE (DE) 2016-08-02 — — US disclosed
US-20120229884-A1 CHARGED PARTICLES BASF SE (DE) 2012-09-13 — — US disclosed
WO-2010149505-A2 CHARGED PARTICLES BASF SE (DE) 2010-12-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120229884-A1 CHARGED PARTICLES POLE3, POLD3, IPO4 MEN1 2903/4885THRB 3898/4885KMT2A 2788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback